Abstract
Uropathogenic Escherichia coli (UPEC) is the leading cause of urinary tract infection (UTI). While the role of UPEC in triggering host immune responses is well studied, less is known about how host-derived cytokines influence UPEC virulence. The aim of this study was to investigate how the pro-inflammatory cytokine IL-1β affects UPEC virulence, metabolism, and host-pathogen interactions. Using the CFT073 strain, we found that IL-1β exposure induced a rapid metabolic shift characterized by decreased oxygen consumption rate (OCR) and increased extracellular acidification rate (ECAR), indicating a transition from respiration to fermentative metabolism. Microarray analysis confirmed the upregulation of fermentative (hyc) and antioxidant (katG, ahpF, grxA) genes, along with increased purine biosynthesis, supporting a metabolic state favouring stress resistance and proliferation. IL-1β also increased fimH and papC gene expression, leading to increased adhesion and invasion of bladder epithelial cells. Furthermore, IL-1β-stimulated CFT073 suppressed the gene expression of several innate immune related genes in a C. elegans infection model. Taken together, our findings suggest that IL-1β induces a virulence-enhancing metabolic change in UPEC, which could enhance its persistence and colonization of the urinary tract. This cross-kingdom signaling may have implications for infection dynamics during a UTI.
Introduction
Uropathogenic Escherichia coli (UPEC) is the predominant cause of urinary tract infection (UTI)1. UPEC possesses a wide array of virulence factors that enable it to colonize, persist, and damage the host urinary tract. These include adhesins such as type-1-fimbriae and P-fimbriae, toxins, siderophores and immune modulators that contribute to host tissue invasion, iron acquisition and immune evasion. UPEC can invade bladder epithelial cells, replicate intracellularly, and form intracellular bacterial communities (IBCs), which are protected from immune detection and antimicrobial treatment2,3,4,5,6. In addition, UPEC can modulate host immune responses, including cytokine production and epithelial barrier integrity, further contributing to chronic infection and recurrence7,8,9.
UTI is an infection characterized by a strong innate immune response. A key component of this response is the release of pro-inflammatory cytokines, which include interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-1β (IL-1β). These cytokines are rapidly induced upon UPEC adhesion to uroepithelial cells and are essential for the recruitment and activation of neutrophils and macrophages at the site of infection10,11,12,13,14,15,16,17,18. IL-1β plays a particularly central role in coordinating early immune responses in the urinary tract18,19. IL-1β is produced as an inactive pro-cytokine and is activated through inflammasome-mediated proteolytic cleavage, leading to its release during epithelial damage or infection18,20. IL-1β not only promotes immune cell infiltration but also drives epithelial remodelling and antimicrobial peptide expression21,22. However, while the host uses IL-1β as a defence mechanism, our recent findings suggest that UPEC can sense IL-1β as a signal to adapt and enhance its virulence23. This cross-kingdom interaction is supported by accumulating evidence showing that IL-1β exposure can enhance bacterial adhesion, biofilm formation, immune evasion, and metabolic reprogramming in pathogens such as Pseudomonas aeruginosa, Staphylococcus aureus and UPEC17,23,24,25. Despite this emerging knowledge, the specific effects of IL-1β on UPEC host-pathogen dynamics remain poorly understood. To address this knowledge gap, we recently investigated how exposure to pro-inflammatory cytokines affect the virulence traits of the UPEC strain CFT073. Our findings showed that IL-1β, along with other cytokines, significantly increased UPEC growth in a concentration-dependent manner. Notably, IL-1β exposure upregulated genes involved in iron acquisition and gluconeogenesis, while simultaneously reducing biofilm formation and hemolytic activity. Interestingly, despite this reduction in hemolytic activity, the overall virulence of UPEC, assessed using a Caenorhabditis elegans (C. elegans) infection model, was increased in the presence of IL-1β 23. Hence, suggesting a complex modulation of bacterial behaviour that favours persistence and host colonization. Despite these initial findings, we still don’t know how IL-1β affects UPEC at a transcriptomic or metabolic level. Given the increasing recognition that pathogens can sense and respond to host-derived cytokines as environmental signals25, it is important to investigate how this crosstalk influences bacterial adaptation and host defence regulation. The aim of this study was to investigate how IL-1β affects UPEC virulence by examining global transcriptional and metabolic changes, as well as its impact on host-pathogen interactions in vivo, using C. elegans as a model.
Materials and methods
Bacteria and bladder epithelial cells
The uropathogenic E. coli strain CFT073 was a kind gift from Professor Harry Mobley at University of Michigan Medical School, MI, USA. CFT073 was kept on tryptic soy agar (TSA) and grown in Lysogeny broth (Difco Laboratories, Detroit, MI, USA) overnight on shaking (150 rpm) at 37 °C prior to experiments. Human bladder epithelial cell line HBLAK (CELLnTEC Advanced Cell Systems AG, Bern, Switzerland), spontaneously immortalized, was grown in Gibco™ EpiLife™ Medium, with 60 µM calcium, supplemented with Gibco™ Human Keratinocyte Growth Supplement (HKGS, ThermoFisher Scientific, MA, USA) at 37 °C, 5% CO2 atmosphere. The complete medium was supplemented with 1 mM CaCl2 24 h prior to experiments.
Microarray analysis
CFT073 (1*106 CFU/ml) was grown in minimal salt medium (MSM, 1.3% [wt/vol] Na2HPO4, 0.3% KH2PO4, 0.05% NaCl, and 0.1% NH4Cl supplemented with 20 mM glucose, 2 mM MgSO4, 100 µM CaCl2, and 0.25% Casamino Acids) with or without the presence of 0.5 ng/ml IL-1β (I9401, Sigma-Aldrich, St. Louis, MO, USA) for 6 hours in a 96-well plate. Total RNA was isolated from the bacteria with the RNeasy Mini Kit (Qiagen Technologies, Hilden, Germany) according to manufacturer instructions. DNA contamination was removed by DNase digestion (TURBO DNase, Life technologies, MA, USA) according to manufacturer instructions. RNA concentration and purity were measured using a Nano-Drop ND-1000 Spectrophotometer (Nano-Drop Technology Inc., Wilmington, DE, USA). RNA quality was also evaluated using a Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA) according to manufacturer instructions. All samples had RNA integrity number (RIN) values above 9. Total RNA from three biological replicates was used to prepare labeled cRNA with Low Input Quick Amp WT Labeling Kits (Agilent) according to manufacturer instructions. Labeled cRNA samples were hybridized in a G2545A hybridization oven (Agilent) onto Agilent SurePrint G3 E. coli Gene Expression 8 × 15k (Agilent Technologies) glass arrays according to manufacturer instructions and subsequently scanned with a G2565 CA array laser scanner (Agilent Technologies). Image analysis and data extraction was performed with Feature Extraction Software (version 10.7.3.1, Agilent Technologies).
RNA isolation, cDNA synthesis and real time-qPCR
CFT073 (1*106 CFU/ml) was grown in MSM with or without the presence of IL-1β (0.5 or 40 ng/ml) in a 96-well plate for 24 h at 37 °C. The bacteria were treated with RNAlater (Sigma-Aldrich) prior to isolation of total RNA using the E.Z.N.A ® Total RNA Kit I (Omega Bio-tek, Inc., Norcross, GA, USA) according to manufacturer instructions. DNA contamination was removed by DNase digestion (TURBO DNase, Life technologies) according to manufacturer instructions. A total of 100 ng was reverse transcribed to cDNA using the High-Capacity cDNA Reverse Transcription Kit for single-stranded cDNA synthesis (Applied Biosystems, CA, USA). Maxima SYBR Green qPCR Master Mix (ThermoFisher Scientific, MA, USA) was used for the real time-qPCR. Each reaction contained 5 ng of template cDNA and 250 nM of each primer (Table 1, Eurofins MWG Synthesis GmbH, Ebersberg, Munich, Germany) was used in the real time-qPCR. A CFX96 Touch™Real-Time PCR Detection System (Biorad, CA, USA) was used for the amplification using the following protocol: initial denaturation at 95 °C for 10 min, 40 cycles of denaturation at 95 °C for 15 s followed by annealing at 60 °C for 30 s and extension at 72 °C for 30 s. The PCR was followed by a dissociation curve analysis between 60 and 95 °C. The Ct values were analyzed by the ΔΔCt method and normalized to the endogenous control gapA (glyceraldehyde 3-phosphate dehydrogenase A). Fold difference was calculated as 2− ΔΔCt.
Invasion and colonization assay
CFT073 (1*106 CFU/ml) was grown in MSM with or without the presence of IL-1β (0.5 or 40 ng/ml) for 24 h in 37 °C. IL-1β was then washed away from the bacteria with PBS. Intracellular bacterial invasion was assessed by stimulating the human bladder epithelial cell line HBLAK with the bacterial at MOI 10 for 2 h at 37 °C with 5% CO2. The cells were washed with PBS after stimulation and the culturing medium was replaced with EpiLife™ Medium complemented with 100 µg/ml gentamicin for an additional 2 h. The cells were thereafter washed, lysed with 0.1% Triton-X 100 in PBS, plated on TSA plates and grown overnight at 37 °C followed by CFU counting. The data is presented as % of CFT073 21.
CFT073 (1*106 CFU/ml) was grown in MSM with or without the presence of IL-1β (0.5 or 40 ng/ml) for 24 h in 37 °C. HBLAK were infected with CFT073 (eGFP, pLMB449 plasmid) at MOI 10 for 4 h at 37 °C with 5% CO2. The assay used to evaluate bacterial colonization (adherent and intracellular bacteria) of HBLAK cells. The HBLAK cells were then washed ten times with PBS, and the fluorescence (eGFP) was measured using the Cytation 3 plate reader. Colonization is presented as mean fluorescence intensity (MFI)21.
Measurement of extracellular oxygen and acid flux
The oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of CFT073 were measured using a Seahorse XF HS Mini Analyzer (Agilent Technologies, Didcot, UK). CFT073 was first cultured overnight in LB broth at 37 °C with shaking (150 rpm). The culture was centrifuged at 4000 × g for 10 min, and the bacterial pellet was resuspended in MSM. A suspension of CFT073 (1*107 CFU/ml) was then transferred to an XF HS miniplate (200 µl final volume per well). The bacteria were subsequently stimulated with IL-1β (0.5 or 40 ng/ml) or left unstimulated and centrifuged at 3000 × g for 10 min. The first OCR and ECAR reading was recorded 30 min after stimulation and continued for 125 min at 37 °C in the analyzer.
Motility assay
CFT073 was grown in MSM with or without the presence of IL-1β (0.5 or 40 ng/ml) for 24 h in 37 °C. A 10 µl suspension of CFT073 at 1*1010 CFU/ml was then stabbed into the middle of a soft agar plate (2.5 g/l agar, 10 g/l tryptone, 5 g/l NaCl) and incubated for 16 h at 30 °C. Bacterial motility was evaluated by measuring the diameter of the migration zone26.
Cytokine release
CFT073 (1*106 CFU/ml) was grown in MSM with or without the presence of IL-1β (0.5 or 40 ng/ml) for 24 h at 37 °C. IL-1β was then washed away from the bacteria with PBS. Cytokine release was assessed by stimulating the human bladder epithelial cell line HBLAK with the bacterial at MOI 10 for 4 h at 37 °C with 5% CO2. The cytokines were measured with the IL-1β, IL-6 and IL-8 kits (ELISA MAX Deluxe Sets, BioLegend, San Diego, CA, United States) according to the manufacturer’s instructions.
C. elegans gene expression
The Bristol wild type N2 strain of C. elegans (Caenorhabditis Genetics Center, University of Minnesota, USA) was maintained on nematode growth medium plates seeded with a lawn of E. coli OP50 at 21 °C. Prior to experiments, C. elegans were alkaline/hypochlorite-synchronized (0.25 M NaOH, 1% HOCl) and maintained on nematode growth medium plates for 48 h at 21 °C to reach L4 stage. CFT073 was grown in MSM with or without the presence of IL-1β (0.5 or 40 ng/ml) for 24 h at 37 °C. IL-1β was then washed away from the bacteria with PBS. Age synchronized L4 worms were washed with MSM and 200 worms were then transferred to respective well of bacteria (5*108 CFU/ml). After the addition of the worm to the wells, C. elegans and the bacteria were incubated together for 5 h at 21 °C. Total RNA was isolated by homogenizing the worms using a TissueLyser LT (Qiagen, Hilden, Germany) (0.5 mm beads, 2 cycles of 2 min at 30 Hz) followed by RNA isolation with the RNeasy plus mini kit (Qiagen). A total of 35 ng RNA was reverse transcribed to cDNA using the High-Capacity cDNA Reverse Transcription Kit for single-stranded cDNA synthesis (Applied Biosystems). Maxima SYBR Green qPCR Master Mix (ThermoFisher Scientific) was used for the real time-qPCR. Each reaction contained 1.75 ng of template cDNA and 250 nM of each primer (Table 1, Eurofins MWG Synthesis GmbH) was used in the real time-qPCR. A CFX96 Touch™Real-Time PCR Detection System (Biorad, ) was used for the amplification using the following protocol: initial denaturation at 95 °C for 10 min, 40 cycles of denaturation at 95 °C for 15 s followed by annealing at 60 °C for 30 s and extension at 72 °C for 30 s. The qPCR was followed by a dissociation curve analysis between 60 and 95 °C. The Ct values were analyzed by the ΔΔCt method and normalized to the endogenous control Y45F10D.4 (FES). Fold difference was calculated as 2− ΔΔCt.
Statistical analysis
Data are shown as mean ± standard error of the mean (SEM), n = number of independent experiments. Differences between groups were assessed by unpaired Student’s t-test. All microarray data analysis was performed using Gene Spring GX version 12.0 (Agilent Technologies) after per chip and gene 75th percentile shift normalization of samples. Differential expression between groups was analyzed with unpaired Student’s t-test. Given the exploratory nature of the study and the relatively small sample size, correction for multiple testing was not applied in order to avoid overlooking potentially biologically relevant genes. Instead, we applied a fold-change cutoff (≥ 1.5) together with pathway-level validation using GO enrichment and KEGG analysis to increase the robustness of the results. Fold change was set at ≥ 1.5 for significantly expressed entities (p < 0.05). GO enrichment and KEGG pathway analysis27,28,29 were conducted with STRING (version 10.5) and significance was set at p < 0.05.
Results
Global transcriptional changes induced by IL-1β stimulation
Microarray profiling was performed on CFT073 following stimulation with IL-1β (0.5 ng/ml) compared to unstimulated CFT073. Differential expression analysis identified that 31 gene entities (Supplementary Table S1) were significantly upregulated, and 45 gene entities (Supplementary Table S2) were significantly downregulated upon IL-1β stimulation (p < 0.05) with at least a ≥ 1.5-fold change compared to unstimulated CFT073. Validation of the microarray data by RT-qPCR for grxA, purL, rlpB, and nirB confirmed the same significant changes in gene expression (Fig. S1). Gene ontology (GO) analysis was performed on significantly altered genes following IL-1β stimulation of CFT073. In total, 14 GO were enriched among upregulated genes (Supplementary Table S3) and 1 (Supplementary Table S4) among downregulated genes. These were mainly related to purine biosynthesis, oxidative stress response, and nucleotide metabolism (Fig. 1A). KEGG pathway analysis identified 3 enriched pathways among upregulated genes (Supplementary Table S5) and 2 (Supplementary Table S6) among downregulated genes. Upregulated pathways included purine metabolism and biosynthesis of secondary metabolites, while downregulated ones were related to glycerolipid and nitrogen metabolism (Fig. 1B).
IL-1β alters the metabolic activity of CFT073
To evaluate the metabolic changes induced by IL-1β, the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of CFT073 were measured following stimulation with IL-1β at 0.5 and 40 ng/ml. IL-1β stimulation induced a rapid decrease in OCR (Fig. 2A), with significantly reduced levels observed after 1.5 (Fig. 2C) and 8 min (Fig. 2D), but not after 14.5 min (Fig. 2E) compared to unstimulated CFT073. In contrast, ECAR measurements showed that IL-1β significantly increased the acidification rate of CFT073 at 1.5 min (Fig. 2F), 8 min (Fig. 2G) and after 14.5 min (Fig. 2H) compared to unstimulated CFT073 (Fig. 2B).
IL-1β stimulation alters CFT073 metabolism. Oxygen consumption rate (OCR, A, C, D, E) and extracellular acidification rate (ECAR, B, F, G, H) was measured in real time in CFT073 following IL-1β stimulation for 125 min. Data are presented as mean ± SEM (n = 8 independent experiments). Asterisks denote statistical significance compared to CFT073 (*p < 0.05, **p < 0.01, ***p < 0.001).
IL-1β enhances adhesion, invasion, and fimbrial gene expression in CFT073
Next, we investigated whether IL-1β stimulation affected CFT073’s fimbriae gene expression and colonization capacity. Real-time qPCR analysis revealed that IL-1β significantly increased the gene expression of the fimbrial genes fimH and papC at 40 ng/ml compared to unstimulated CFT073 (Fig. 3A, B). To determine the functional relevance of these changes, we assessed bacterial colonization and invasion of human bladder epithelial cells. CFT073 stimulated with IL-1β significantly increased the colonization of bladder epithelial cells at both 0.5 and 40 ng/ml compared to unstimulated CFT073 (Fig. 3C). Furthermore, CFT073 invasion of bladder epithelial cells was significantly increased after IL-1β stimulation at 0.5 ng/ml, but not 40 ng/ml compared to unstimulated CFT073 (Fig. 3D). In addition, we also observed that IL-1β stimulation of CFT073 did not affect the motility of CFT073 (Fig. 3E).
Increased bacterial colonization and invasion. Real time-qPCR analysis of fimH (A) and papC (B) mRNA expression in the presence or absence of IL-1β (0.5 or 40 ng/ml) after 24 h. Data are presented as mean ± SEM of n = 3–4 independent experiments. CFT073 colonization (C) and invasion (D) of bladder epithelial cells in the presence or absence of IL-1β (0.5 or 40 ng/ml) after 2 h (C) and 4 h (D). Colonization was quantified as mean fluorescence intensity (MFI) (C). Data are presented as mean ± SEM of n = 4–5 independent experiments. CFT073 motility assay in the presence or absence of IL-1β (0.5 or 40 ng/ml) after 16 h (E). Data are presented as mean ± SEM of n = 5 independent experiments. Asterisks denote statistical significance compared to CFT073 (*p < 0.05).
IL-1β-stimulated CFT073 did not increase the release of cytokines or chemokines
We proceeded with evaluating if IL-1β-stimulated CFT073 could influence cytokine or chemokine release from bladder epithelial cells. CFT073 alone and IL-1β-stimulated CFT073 significantly increased the release of IL-1β compared to unstimulated cells (Fig. 4A). However, this increased release was not altered by IL-1β-stimulated CFT073 compared to unstimulated CFT073 (Fig. 4A). No significant differences were observed in IL-6 (Fig. 4B) or IL-8 (Fig. 4C) release between IL-1β-stimulated CFT073 and unstimulated CFT073.
Cytokine release from bladder epithelial cells. Bladder epithelial cells we infected with CFT073 or IL-1β-stimulated CFT073 (0.5 or 40 ng/ml) at MOI 10 for 4 h followed by analysis of IL-1β (A), IL-6 (B) and IL-8 (C) release. Data are presented as mean ± SEM (n = 4 independent experiments). Asterisks denote statistical significance compared to unstimulated cells (***p < 0.001).
IL-1β-stimulated CFT073 downregulates innate immune genes in C. elegans
To determine whether IL-1β stimulation of CFT073 affects host immune responses, we evaluated the expression of selected C. elegans immune and stress-related genes following CFT073 infection. Several C. elegans genes were significantly downregulated in worms infected with IL-1β-stimulated CFT073. We found that the gene expression of abf-2 (Fig. 5A), ape-1 (Fig. 5B), Cep-1 (Fig. 5D), lys-7 (Fig. 5E) and Tir-1 (Fig. 5F) were significantly decreased after infection with IL-1β-stimulated CFT073 compared to unstimulated CFT073. However, we did not observe any significant changes in the expression of bar-1 (Fig. 5C) or wah-1 (Fig. 5G).
C. elegans mRNA expression. C. elegans worms we infected with CFT073 or IL-1β-stimulated CFT073 (0.5 or 40 ng/ml) for 5 h followed by analysis of gene expression of Abf-2 (A), Ape-1 (B), Bar-1 (C), Cep-1 (D), Lys-7 (E), Tir-1 (F) and Wah-1 (G). Data are presented as mean ± SEM (n = 4 independent experiments). Asterisks denote statistical significance compared to CFT073 (*p < 0.05, **p < 0.01, ***p < 0.001).
Discussion
Understanding the interplay between UPEC and the host immune system is important, particularly considering the increasing antibiotic resistance that is limiting treatment options. In this study, we investigated the cross-kingdom impact of the pro-inflammatory cytokine IL-1β on UPEC virulence and metabolic adaptation. We chose to focus on IL-1β, as it is one of the most potent pro-inflammatory cytokines and it has been linked to dysregulated inflammation and to the severity of UTI16,19,30,31,32. We have previously also shown that IL-1β can enhance UPEC virulence traits, including increased bacterial growth23.
Our findings showed a rapid inverse relationship between OCR and ECAR following IL-1β stimulation. We found that changes in ECAR, but not in OCR, were dependent on the IL-1β concentration. This indicates a metabolic shift in CFT073 from oxygen-dependent respiration toward acidogenic, fermentative metabolism. In E. coli, this shift may be explained by an overflow metabolism33 or strict anaerobic fermentation. In both cases, pyruvate is converted by pyruvate-formate lyase into formate and acetyl-CoA. Formate is then further processed by the formate hydrogen lyase (FHL-1) complex, encoded by the hyc operon, producing CO₂, H₂, and different organic acids. This will then lead to an increased ECAR34,35, as observed in our experiments. This metabolic shift is supported by our microarray data showing that the hyc genes are significantly upregulated (Supplementary Table S1), while the formate transporter focA is downregulated. This will likely promote intracellular formate retention and sustained FHL-1 activity. In addition, genes involved in nitrate and nitrite respiration (napA, nirB, nirD) are downregulated, indicating suppression of anaerobic respiration36,37.
Next, we also observed an upregulation of the antioxidant defense genes katG (catalase-peroxidase), ahpCF (alkyl hydroperoxide reductase) and grxA (glutaredoxin) in IL-1β-stimulated CFT073. The upregulation of these genes suggests an activation of the OxyR peroxide-sensing regulatory system in CFT073. OxyR is a redox-sensitive transcription factor that responds to hydrogen peroxide and triggers the expression of antioxidant defense genes, especially katG, ahpCF and grxA38,39. These enzymes buffer intracellular ROS and restore redox balance. This is essential adaptation during infection, where oxidative stress can arise both from host immune responses and from metabolic shifts such as increased fermentation38,39. Enrichment analysis showed that the GO terms; response to reactive oxygen species, cellular response to hydrogen peroxide and cell redox homeostasis were significantly enriched based on our microarray data. This supports an activation of the OxyR peroxide-sensing regulatory system. Furthermore, in the context of UPEC pathogenesis, OxyR plays an important role in promoting bacterial survival during inflammatory conditions40,41. The urinary tract is a hostile milieu full of neutrophil-derived ROS and reactive nitrogen species, particularly during IL-1β-driven immune activation42. Previous studies have shown that UPEC strains lacking OxyR are significantly impaired in their ability to colonize the bladder, highlighting its importance as a virulence factor40,43.
Our microarray analysis also showed significant upregulation of purine biosynthesis genes (purL, purF, purH and purK) in response to IL-1β stimulation. This was accompanied by the enrichment of the KEGG “purine metabolism” pathway. De novo purine synthesis is essential for maintaining nucleotide pools required for DNA replication, RNA transcription, and energy transfer. Functions that are important during rapid bacterial growth in nutrient-limited environments like the urinary tract44. Studies have shown that purine biosynthesis contributes directly to UPEC fitness and virulence, with pur mutants showing impaired bladder colonization45,46. Taken together, these findings may suggest that IL-1β stimulation promotes a metabolic and redox state that supports UPEC persistence during immune-mediated stress. Activation of the OxyR regulon enhances oxidative stress tolerance, while increased purine biosynthesis ensures sufficient nucleotide availability to sustain growth and colonization. Together, these responses may contribute to a virulence-enhancing metabolic adaptation that could favour UPEC survival in the urinary tract.
We next investigated whether IL-1β influences the ability of CFT073 to adhere to and invade bladder epithelial cells, based on the upregulation of genes observed in our microarray data. We found that the type-1 fimbriae (fimH) and the P-fimbriae (papC) were upregulated by IL-1β. We also observed that IL-1β increased CFT073’s ability to colonize (adhesion/invasion) and invade bladder epithelial cells, in a dose dependent way. The ability of UPEC to adhere to and invade uroepithelial cells is a key step in the establishment of UTI. The type-1-fimbriae is primarily involved in bladder colonization, while P-fimbriae facilitate attachment to the kidney epithelium5,47. In addition, we also evaluated UPEC motility and found no changes induced by IL-1β. Furthermore, since the release of IL-6, IL-8, and IL-1β play an important role in the host response to UPEC and other bacteria13,15,16,17,18,22,48,49,50,51, we next investigated whether IL-1β-stimulated CFT073 could modulate cytokine release from bladder epithelial cells. We found that IL-1β-stimulated CFT073 did not increase the release of IL-6, IL-8 or IL-1β from bladder epithelial cells. However, additional cytokines and chemokines should be examined in future studies to rule out the possibility that IL-1β-stimulated CFT073 alters their release. Hence, UPECs ability to sense IL-1β and upregulate fimH and papC, in combination with the increased adhesion and invasion of bladder epithelial cells, may indicate a promoted persistence in the urinary tract.
To further evaluate how IL-1β-induced changes in CFT073 contribute to overall virulence, we continued using a C. elegans infection model. This model has previously been validated for assessing UPEC pathogenicity and has shown to correlate well with murine infection outcomes23,52,53. We found that C. elegans infected with IL-1β-stimulated CFT073 downregulated several genes involved in innate immunity: abf-2 (antimicrobial peptide), lys-7 (lysozyme), and tir-1 (Toll and Interleukin 1 Receptor-1), as well as stress-response genes (ape-1, cep-1). Each of these genes contributes to nematode defense or stress tolerance54,55,56. Their downregulation indicates that IL-1β-stimulated UPEC actively dampens/suppresses host defense responses in C. elegans. Interestingly, these changes did not seem to be dose dependent. UPECs ability to modulate the immune response has been shown to be a key aspect of its virulence in the urinary tract7,8,9. We have previously shown that IL-1β-stimulated CFT073 decreased the survival of C. elegans23. Our current findings suggest that the suppressed immune response induced by IL-1β-stimulated CFT073 may partly account for this increased lethality.
As antibiotic resistance in UPEC continues to rise, targeting bacterial virulence offers a promising alternative to traditional therapies. Our study shows that IL-1β, a key inflammatory cytokine, enhances UPEC virulence by inducing metabolic and transcriptional changes that promote fermentative growth, oxidative stress resistance, and purine biosynthesis. These adaptations could support bacterial survival under immune pressure and increase adhesion, invasion, and immune suppression in the host. These findings highlight a paradox where host inflammation may unintentionally enhance pathogen fitness. Targeting these host–bacterial interactions may offer new strategies for preventing or managing UPEC infections.
Data availability
All data generated or analysed during this study are included in this published article (and its Supplementary Information files). Gene expression data is available upon request.
References
Foxman, B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. N. Am. 28, 1–13. https://doi.org/10.1016/j.idc.2013.09.003 (2014).
Mulvey, M. A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494–1497. https://doi.org/10.1126/science.282.5393.1494 (1998).
Mulvey, M. A., Schilling, J. D., Martinez, J. J. & Hultgren, S. J. Bad Bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl. Acad. Sci. U.S.A. 97, 8829–8835 (2000).
Wiles, T. J., Kulesus, R. R. & Mulvey, M. A. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85, 11–19 (2008).
Flores-Mireles, A. L., Walker, J. N., Caparon, M. & Hultgren, S. J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13, 269–284. https://doi.org/10.1038/nrmicro3432 (2015).
Subashchandrabose, S. & Mobley, H. L. Virulence and fitness determinants of uropathogenic Escherichia coli. Microbiol. Spectr. 3 https://doi.org/10.1128/microbiolspec.UTI-0015-2012 (2015).
Hunstad, D. A., Justice, S. S., Hung, C. S., Lauer, S. R. & Hultgren, S. J. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect. Immun. 73, 3999–4006 (2005).
Billips, B. K., Schaeffer, A. J. & Klumpp, D. J. Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect. Immun. 76, 3891–3900 (2008).
Hilbert, D. W. et al. Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide- and Toll-like receptor 4-independent pathway. Microbes Infect. 10, 114–121 (2008).
Scott, L. M. et al. Production and regulation of interleukin-1 family cytokines at the materno-fetal interface. Cytokine 99, 194–202. https://doi.org/10.1016/j.cyto.2017.07.005 (2017).
Samuelsson, P., Hang, L., Wullt, B., Irjala, H. & Svanborg, C. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect. Immun. 72, 3179–3186 (2004).
Khalil, A. et al. Renal cytokine responses in acute Escherichia coli pyelonephritis in IL-6-deficient mice. Clin. Exp. Immunol. 122, 200–206 (2000).
Svanborg, C., Godaly, G. & Hedlund, M. Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr. Opin. Microbiol. 2, 99–105 (1999).
Hedges, S. & Svanborg, C. The mucosal cytokine response to urinary tract infections. Int. J. Antimicrob. Agents. 4, 89–93. https://doi.org/10.1016/0924-8579(94)90039-6 (1994).
Lindblad, A., Johansson, C., Persson, K. & Demirel, I. The role of caspase-1, caspase-4 and NLRP3 in regulating the host cell response evoked by uropathogenic Escherichia coli. Sci. Rep. 12, 2005. https://doi.org/10.1038/s41598-022-06052-7 (2022).
Lindblad, A., Persson, K. & Demirel, I. J. C. IL-1RA is part of the inflammasome-regulated immune response in bladder epithelial cells and influences colonization of uropathogenic E. coli. 123, 154772 (2019).
Demirel, I. et al. Activation of NLRP3 by uropathogenic is associated with IL-1β release and regulation of antimicrobial properties in human neutrophils. Sci. Rep-Uk. 10 https://doi.org/10.1038/s41598-020-78651-1 (2020).
Demirel, I. et al. Activation of the NLRP3 inflammasome pathway by uropathogenic Escherichia coli is virulence factor-dependent and influences colonization of bladder epithelial cells. Front. Cell. Infect. Mi. https://doi.org/10.3389/fcimb.2018.00081 (2018).
Nagamatsu, K. et al. Dysregulation of Escherichia coli alpha-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc. Natl. Acad. Sci. U.S.A. 112, E871–880. https://doi.org/10.1073/pnas.1500374112 (2015).
Paik, S. et al. Updated insights into the molecular networks for NLRP3 inflammasome activation. Cell Mol. Immunol. 22, 563–596. https://doi.org/10.1038/s41423-025-01284-9 (2025).
Lindblad, A., Wu, R. R., Persson, K. & Demirel, I. The role of NLRP3 in regulation of antimicrobial peptides and Estrogen signaling in UPEC-Infected bladder epithelial cells. Cells-Basel 12 https://doi.org/10.3390/cells12182298 (2023).
Kuhn, H. W., Hreha, T. N. & Hunstad, D. A. Immune defenses in the urinary tract. Trends Immunol. 44, 701–711. https://doi.org/10.1016/j.it.2023.07.001 (2023).
Engelsöy, U., Rangel, I. & Demirel, I. Impact of Proinflammatory cytokines on the virulence of uropathogenic Escherichia coli. Front. Microbiol. 10 https://doi.org/10.3389/fmicb.2019.01051 (2019).
Jauregui, R. G. et al. IL-1β promotes biofilms on implants. Front Immunol., (2019). 108210.3389/fimmu.2019.01082.
Hitzler, S. U. J., Fernández-Fernández, C., Montaño, D. E., Dietschmann, A. & Gresnigt, M. S. Microbial adaptive pathogenicity strategies to the host inflammatory environment. Fems Microbiol. Rev. https://doi.org/10.1093/femsre/fuae032 (2025).
Sudarshan, S., Hogins, J., Ambagaspitiye, S., Zimmern, P. & Reitzer, L. Nutrient and energy pathway requirements for surface motility of nonpathogenic and uropathogenic. J. Bacteriol..10.1128/JB.00467 – 20. (2021).
Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 https://doi.org/10.1093/nar/gkae909 (2025).
Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (462), D457. https://doi.org/10.1093/nar/gkv1070 (2016).
Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30. https://doi.org/10.1093/nar/28.1.27 (2000).
Waldhuber, A. et al. Uropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activation. J. Clin. Investig. 126, 2425–2436. https://doi.org/10.1172/JCI81916 (2016).
Verma, V. et al. Involvement of NLRP3 and NLRC4 inflammasome in uropathogenic E. coli mediated urinary tract infections. Front. Microbiol. https://doi.org/10.3389/fmicb.2019.02020 (2019).
Ambite, I. et al. Molecular basis of acute cystitis reveals susceptibility genes and immunotherapeutic targets. PLoS Pathog. https://doi.org/10.1371/journal.ppat.1005848 (2016).
Basan, M. et al. Overflow metabolism in Escherichia coli results from efficient proteome allocation. Nature 528, 99–104. https://doi.org/10.1038/nature15765 (2015).
McDowall, J. S. et al. Bacterial formate Hydrogenlyase complex. Proc. Natl. Acad. Sci. U.S.A. 111, E3948–E3956. https://doi.org/10.1073/pnas.1407927111 (2014).
Steinhilper, R., Höff, G., Heider, J. & Murphy, B. J. Structure of the membrane-bound formate Hydrogenlyase complex from. Nat. Commun. 13 https://doi.org/10.1038/s41467-022-34914-1 (2022).
Durand, S. & Guillier, M. Transcriptional and post-transcriptional control of the nitrate respiration in bacteria. Front. Mol. Biosci. 8 https://doi.org/10.3389/fmolb.2021.667758 (2021).
Stewart, V., Bledsoe, P. J. & Fnr- NarP- and NarL-dependent regulation of transcription initiation from the Rd (Periplasmic nitrate reductase) promoter in K-12. J. Bacteriol. 187, 6928–6935. https://doi.org/10.1128/Jb.187.20.6928-6935.2005 (2005).
Michán, C., Manchado, M., Dorado, G. & Pueyo, C. In vivo transcription of the Regulon as a function of growth phase and in response to oxidative stress. J. Bacteriol. 181, 2759–2764 (1999).
Zheng, M. et al. Computation-directed identification of OxyR DNA binding sites in. J. Bacteriol. 183, 4571–4579. https://doi.org/10.1128/Jb.183.15.4571-4579.2001 (2001).
Johnson, J. R. et al. OxyR contributes to the virulence of a clonal group A strain (O17:K+:H18) in animal models of urinary tract infection, subcutaneous infection, and systemic sepsis. Microb. Pathog. 64, 1–5. https://doi.org/10.1016/j.micpath.2013.07.001 (2013).
Li, X. P. et al. Nucleoside-diphosphate kinase of uropathogenic inhibits caspase-1-dependent pyroptosis facilitating urinary tract infection. Cell Rep. 43,10.1016/j.celrep.114051 (2024).
Abraham, S. N. & Miao, Y. The nature of immune responses to urinary tract infections. Nat. Rev. Immunol. 15, 655–663. https://doi.org/10.1038/nri3887 (2015).
Johnson, J. R., Clabots, C. & Rosen, H. Effect of inactivation of the global oxidative stress regulator on the colonization ability of O1:K1:H7 in a mouse model of ascending urinary tract infection. Infect. Immun. 74, 461–468. https://doi.org/10.1128/Iai.74.1.461-468.2006 (2006).
Jensen, K. F., Dandanell, G., Hove-Jensen, B. & WillemoEs, M. Nucleotides, Nucleosides, and nucleobases. EcoSal Plus. https://doi.org/10.1128/ecosalplus.3.6.2 (2008).
Andersen-Civil, A. I. S. et al. The impact of inactivation of the purine biosynthesis genes, and, on growth and virulence in uropathogenic. Mol. Biol. Rep. 45, 2707–2716. https://doi.org/10.1007/s11033-018-4441-z (2018).
Shaffer, C. L. et al. Purine biosynthesis metabolically constrains intracellular survival of uropathogenic. Infection Immun. 85, (2017). 10.1128/IAI.00471 – 16.
Korhonen, T. K., Virkola, R. & Holthofer, H. Localization of binding sites for purified Escherichia coli P fimbriae in the human kidney. Infect. Immun. 54, 328–332 (1986).
Jayaprakash, K., Demirel, I., Gunaltay, S., Khalaf, H. & Bengtsson, T. PKC, ERK/p38 MAP kinases and NF-kappa B targeted signalling play a role in the expression and release of IL-1 beta and CXCL8 in Porphyromonas gingivalis-infected THP1 cells. APMIS: Acta Pathologica Microbiol. Et Immunol. Scand. 125, 623–633. https://doi.org/10.1111/apm.12701 (2017).
Demirel, I. et al. Nitric oxide activates IL-6 production and expression in human renal epithelial cells. Am. J. Nephrol. 36, 524–530. https://doi.org/10.1159/000345351 (2012).
Klarström Engström, K., Zhang, B. & Demirel, I. Human renal fibroblasts are strong immunomobilizers during a urinary tract infection mediated by uropathogenic Escherichia coli. Sci. Rep-Uk. 9, 2296. https://doi.org/10.1038/s41598-019-38691-8 (2019).
Palm, E., Demirel, I., Bengtsson, T. & Khalaf, H. The role of toll-like and protease-activated receptors and associated intracellular signaling in Porphyromonas gingivalis-infected gingival fibroblasts. APMIS: Acta Pathologica Microbiol. Et Immunol. Scand. 125, 157–169. https://doi.org/10.1111/apm.12645 (2017).
52 Diard, M. et al. Caenorhabditis elegans as a simple model to study phenotypic and genetic virulence determinants of extraintestinal pathogenic Escherichia coli. Microbes Infect. 9, 214–223. https://doi.org/10.1016/j.micinf.2006.11.009 (2007).
Wu, R., Pettersson, C. & Demirel, I. Testosterone increases the virulence traits of uropathogenic Escherichia coli. Front. Microbiol. 15 https://doi.org/10.3389/fmicb.2024.1422747 (2024).
Tran, T. D. & Luallen, R. J. An organismal Understanding of C. elegans innate immune responses, from pathogen recognition to multigenerational resistance. Semin Cell. Dev. Biol. 154, 77–84. https://doi.org/10.1016/j.semcdb.2023.03.005 (2024).
Martineau, C. N., Kirienko, N. V. & Pujol, N. Innate immunity in. Curr. Top. Dev. Biol. 144, 309–351. https://doi.org/10.1016/bs.ctdb.2020.12.007 (2021).
Kumar, R. et al. Comparative analysis of stress induced gene expression in following exposure to environmental and lab reconstituted complex metal mixture. PloS One. https://doi.org/10.1371/journal.pone.0132896 (2015).
Acknowledgements
This project was financially supported by the Faculty of Medicine and Health at Örebro University.
Funding
Open access funding provided by Örebro University.
Author information
Authors and Affiliations
Contributions
ID, RW, FK and IR design the study. ID, RW and FK conducted the experiments. ID, RW, FK and IR analyzed the data. ID, RW, FK and IR drafted the article. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kalaycı-Yüksek, F., Wu, R., Rangel, I. et al. IL-1β alters the virulence of uropathogenic Escherichia coli. Sci Rep 15, 37750 (2025). https://doi.org/10.1038/s41598-025-26055-4
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-26055-4




